Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu

Syneos Health Inc (SYNH)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,650,811
  • Shares Outstanding, K 103,226
  • Annual Sales, $ 2,672 M
  • Annual Income, $ -138,470 K
  • 36-Month Beta 1.51
  • Price/Sales 1.31
  • Price/Cash Flow 14.26
  • Price/Book 1.96

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 12/31/18
See More
  • Average Estimate 0.73
  • Number of Estimates 5
  • High Estimate 0.74
  • Low Estimate 0.70
  • Prior Year 0.67
  • Growth Rate Est. (year over year) +8.96%

Price Performance

See More
Period Period Low Period High Performance
1-Month
47.98 +14.32%
on 01/22/19
55.00 -0.27%
on 02/19/19
+5.51 (+11.17%)
since 01/18/19
3-Month
36.26 +51.25%
on 12/24/18
55.00 -0.27%
on 02/19/19
+8.35 (+17.96%)
since 11/19/18
52-Week
31.10 +76.37%
on 02/22/18
55.00 -0.27%
on 02/19/19
+16.45 (+42.84%)
since 02/16/18

Most Recent Stories

More News
Syneos Health Schedules Fourth Quarter and Year End 2018 Earnings Call for Thursday, February 28, 2019

Syneos Health (Nasdaq: SYNH), the only fully integrated biopharmaceutical solutions organization combining a Contract Research Organization (CRO) and Contract Commercial Organization (CCO), will release...

SYNH : 54.85 (+0.20%)
Today's Research Reports on Trending Tickers: Syneos Health and Charles River Laboratories International

NEW YORK, NY / ACCESSWIRE / January 9, 2019 / U.S. equities closed up on Tuesday as market participants await details from the recent negotiations in Washington between U.S. and senior Chinese officials....

SYNH : 54.85 (+0.20%)
Syneos Health to Share Critical Insights for Maximizing Value and Fueling Commercial Success at Biotech Showcase Events

Syneos Health(TM) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, will share new research and real-world insights for driving shareholder value and increasing the likelihood...

MHMNF : 54.5000 (unch)
SYNH : 54.85 (+0.20%)
SYNH vs. NXGN: Which Stock Is the Better Value Option?

SYNH vs. NXGN: Which Stock Is the Better Value Option?

NXGN : 18.56 (-1.01%)
SYNH : 54.85 (+0.20%)
Syneos Health to Present at the 37th Annual J.P. Morgan Healthcare Conference

Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization combining a CRO (Contract Research Organization) and a CCO (Contract Commercial Organization), today announced...

JPM : 105.18 (-0.35%)
SYNH : 54.85 (+0.20%)
John M. Dineen Appointed to Syneos Health Board of Directors, Named Chairman

Syneos Health(TM) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced that John M. Dineen has been appointed to the Company's Board of Directors and named...

SYNH : 54.85 (+0.20%)
CTSH : 73.18 (-0.52%)
MACK : 5.93 (+1.19%)
SYNH vs. CRL: Which Stock Is the Better Value Option?

SYNH vs. CRL: Which Stock Is the Better Value Option?

SYNH : 54.85 (+0.20%)
CRL : 141.13 (+0.19%)
Syneos Health Releases the 2019 Health Trend Ten, Outlining Critical Shifts Impacting Drug Development and Commercialization

Syneos Health(TM) (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today released a trends forecast outlining critical shifts and the underlying dynamics that will shape...

SYNH : 54.85 (+0.20%)
Syneos Health Announces Corporate Leadership Positions

Jonathan Olefson Joins as General Counsel and Corporate Secretary

SYNH : 54.85 (+0.20%)
Zacks.com featured highlights include: Gray Television, Syneos, Dollar General, Sabre and Jones Lang

Zacks.com featured highlights include: Gray Television, Syneos, Dollar General, Sabre and Jones Lang

GTN : 17.64 (-1.07%)
DG : 119.15 (+0.13%)
SYNH : 54.85 (+0.20%)
SABR : 22.45 (-0.36%)
JLL : 164.86 (-0.06%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 88% Buy with a Strongest short term outlook on maintaining the current direction.

Longer term, the trend strength is Strong. Long term indicators mostly agree with the trend.

The market is in highly overbought territory. Beware of a trend reversal.

See More Share

Trade SYNH with:

Business Summary

Syneos Health Inc. is an integrated biopharmaceutical solutions organization. It includes a Contract Research Organization and Contract Commercial Organization to accelerate customer performance to address modern market realities. Syneos Health Inc., formerly known as INC Research Holdings Inc., is based...

See More

Key Turning Points

2nd Resistance Point 55.45
1st Resistance Point 55.15
Last Price 54.85
1st Support Level 54.40
2nd Support Level 53.96

See More

52-Week High 55.00
Last Price 54.85
Fibonacci 61.8% 45.87
Fibonacci 50% 43.05
Fibonacci 38.2% 40.23
52-Week Low 31.10

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Read About Upcoming
Changes to This Feature
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar